News Releases 2016

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Keyword Search
 
Search by Year
DateTitle 
12/01/16Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering TechnologyPrinter Friendly Version
11/10/16Charles River Laboratories Presents Robust Program at Neuroscience 2016Printer Friendly Version
11/02/16Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
10/11/16Charles River Announces Extension of Integrated Discovery Program with GenentechPrinter Friendly Version
10/06/16Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
09/28/16Charles River Laboratories Acquires Agilux Laboratories, Inc.Printer Friendly Version
09/22/16Charles River Laboratories and The Tri-Institutional Therapeutics Discovery Institute Announce Strategic PartnershipPrinter Friendly Version
09/06/16Charles River Laboratories to Present at September Investor ConferencesPrinter Friendly Version
08/08/16Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and ConsortiumPrinter Friendly Version
08/03/16Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
07/11/16Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
06/27/16Charles River Laboratories Acquires Blue Stream LaboratoriesPrinter Friendly Version
06/06/16Charles River Laboratories to Present at Jefferies and William Blair ConferencesPrinter Friendly Version
06/06/16Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna’s Nonclinical Development Efforts for Novel mRNA TherapeuticsPrinter Friendly Version
05/04/16Charles River Laboratories Announces First-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
04/13/16Charles River Laboratories and BioMotiv Enter into Strategic PartnershipPrinter Friendly Version
04/07/16Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
04/04/16Charles River Laboratories Completes the Acquisition of WIL ResearchPrinter Friendly Version
03/07/16Charles River Laboratories to Present at Raymond James ConferencePrinter Friendly Version
02/10/16Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 GuidancePrinter Friendly Version
01/20/16Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference CallPrinter Friendly Version
01/07/16Charles River Laboratories to Acquire WIL ResearchPrinter Friendly Version